Stockwinners Market Radar for September 29, 2017 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service |
AIG | Hot Stocks18:28 EDT AIG CEO 'welcomes' FSOC decision to rescind SIFI designation - American International Group issued the following statement from AIG President and CEO Brian Duperreault regarding the Financial Stability Oversight Council's decision to remove AIG's designation as a Systemically Important Financial Institution: "I welcome the decision by the Financial Stability Oversight Council to rescind AIG's SIFI designation. The Council's decision reflects the substantial and successful de-risking that AIG's employees have achieved since 2008. The company is committed to continued vigilant risk management and to working closely with our numerous regulators to enable a strong AIG to continue to serve our clients."
|
IPDN | Hot Stocks18:17 EDT Professional Diversity Network executes consultancy agreement with Chris Wesser - Professional Diversity Network announced that it has executed a consultancy agreement with Chris Wesser. Chris Wesser has served as the Executive Vice President, General Counsel and Corporate Secretary of Professional Diversity Network since September 24, 2014. Effective September 24, 2017, Wesser's employment with IPDN has ended. IPDN has offered and Wesser has accepted the opportunity to continue to provide consulting services to IPDN on an independent contractor basis.
|
SNCR | Hot Stocks18:06 EDT Synchronoss issues statement regarding strategic alternatives process - Synchronoss Technologies issued the following statement regarding the Board of Directors' ongoing strategic alternatives process: "Synchronoss' Board of Directors continues to be committed to enhancing value for all shareholders. The Board's strategic alternatives process remains underway and it continues to explore a full range of strategic, operational and financial alternatives. Siris Capital Partners recently informed Synchronoss that Siris would terminate its discussions regarding a potential transaction unless Synchronoss agreed to negotiate exclusively with Siris. Given the status of the process and the continued interest from other parties, Synchronoss has determined that entering into an exclusivity agreement with Siris at this time is not in the best interest of the Company's shareholders. The Company remains in active discussions with multiple parties and has received what the Board believes to be attractive proposals compared to the most recent proposal from Siris. The Board will carefully consider all options and make a decision that reflects the best interest of all shareholders and maximizes value. There can be no assurance as to whether or not any transaction will take place, the structure of such a transaction, or the ultimate timing."
|
AIG | Hot Stocks18:06 EDT FSOC rescinds nonbank financial company designation for AIG - The Financial Stability Oversight Council announced that it has rescinded its determination that material financial distress at American International Group, Inc. could pose a threat to U.S. financial stability and that AIG shall be subject to supervision by the Board of Governors and enhanced prudential standards. "The Council has worked diligently to thoroughly reevaluate whether AIG poses a risk to financial stability," said Treasury Secretary Steven T. Mnuchin. "This action demonstrates our commitment to act decisively to remove any designation if a company does not pose a threat to financial stability." Reference Link
|
NOAH | Hot Stocks18:03 EDT Noah Holdings to buy Sequoia Capital China's stake in asset management business - Noah Holdings announced it has agreed to repurchase Sequoia Capital China's stake in its asset management business. In October 2016, Beijing Sequoia Mingde Equity Investment Center entered into an investment and cooperation agreement with the Company to purchase a certain equity stake in Noah's asset management business held through Gopher Asset Management Co. As a result of recent Chinese regulatory changes, the completion of the restructuring contemplated in connection with this investment by Sequoia in Gopher requires substantially longer time than originally expected. After careful discussions, the Company and Sequoia mutually agreed to cancel this investment and have the Company repurchase all of Sequoia's equity stake in Gopher for an aggregate amount of approximately $53.9M. After such repurchase is completed, Sequoia will not have any direct equity interests in the Company's asset management business but will remain an important shareholder of the Company.
|
TERP | Hot Stocks17:56 EDT TerraForm Power sees Brookfield transaction to close early in Q4 - "Our team remains focused on the operations of our fleet and on meeting the outstanding closing conditions for the Brookfield transaction, which include the receipt of regulatory approval in Chile and Canada, and shareholder approval of the transaction. A special meeting of our stockholders to vote on the Brookfield transaction is scheduled for October 6, 2017. We continue to expect the transaction to close early in the fourth quarter," said Peter Blackmore, Chairman and Interim CEO of TerraForm Power. TerraForm Power said separately in a regulatory filing that Brookfield has informed the company that it expects to relocate the Company's headquarters to New York, New York, following the closing of the Sponsorship Transaction. As a result, the company expects to experience a significant turnover in its current workforce based on this relocation. "This turnover and other reductions in our workforce may cause the company to experience disruptions to our operations, including as a result of the departure of employees with institutional knowledge of the company's business. These disruptions could have an adverse effect on our business," the company added.
|
TRN... | Hot Stocks17:40 EDT On The Fly: After Hours Movers - HIGHER: Trinity Industries (TRN), up 8.9% after Bloomberg reported that the $663M guardrail fraud judgment against the company was reversed... Scorpio Tankers (SCG), up 5.2% after it announced sale and leaseback agreements for five tankers... Mylan (MYL), up 1.9% after it announced the U.S. launch of generic Gleevec tablets. LOWER: Talend (TLND), down 7.2% after it filed to sell 10.53M American Depositary Shares for holders.
|
IHRT | Hot Stocks17:34 EDT iHeartMedia says no agreement reached with lenders on exchange discussions - On March 15, iHeartCommunications commenced exchange offers to exchange certain series of its outstanding series of debt securities for new securities of iHeartCommunications, iHeartMedia, and CC Outdoor Holdings and concurrent consent solicitations with respect to the existing notes. In addition, on March 15, iHeartCommunications also commenced offers to amend its outstanding Term Loan D and Term Loan E borrowings under its senior secured credit facility. As previously disclosed, iHeartCommunications has engaged in discussions with certain lenders under its Term Loan D and Term Loan E facilities and certain priority guarantee noteholders and counsel to certain of those Lenders in connection with the Term Loan Offers. No agreement has been reached with respect to the above discussions and discussions remain ongoing. There can be no assurance that any agreement will be reached. Any such agreement will require the consent of additional debt holders who are not party to the negotiations, and who hold substantial percentages of our debt.
|
PH... | Hot Stocks17:27 EDT Parker Aerospace and Lufthansa announce long-term agreement for Airbus A350 MRO - Parker Aerospace, a business group of Parker Hamlin (PH), announced an agreement with Lufthansa Technik (DLAKY) for long-term collaboration for Airbus A350 component maintenance, repair, and overhaul, or MRO services. The agreement covers the majority of repairable components for the Parker-designed A350 fuel, hydraulic, and fuel tank inerting systems. The agreement between Lufthansa Technik and Parker Aerospace will encompass the joint development of repair procedures to increase component and systems reliability and reduce related maintenance costs for airline customers worldwide. Airbus (EADSY) and operators benefit from shared best practices and collaborative approaches to continuous improvement in repair performance. The collaboration will help optimize services by focusing on repair development, instead of replacing components, keeping them in flight longer to reduce costs.
|
MGA | Hot Stocks17:21 EDT Magna to pay C$25M to settle KS Centoco legal proceedings - Magna International announced that it has reached a settlement agreement with the plaintiffs in the KS Centoco Ltd. legal proceedings. Under the settlement agreement, Magna will relinquish its 23% equity interest in KS Centoco and pay C$25M in exchange for a full and final release of all claims. Although the full terms of the settlement agreement are subject to confidentiality restrictions, the impact of the settlement on Magna's financial condition and results of operations is not significant.
|
LMT | Hot Stocks17:19 EDT Lockheed Martin awarded $418.6M government contract modification - Lockheed Martin Space Systems Co., Sunnyvale, California, is being awarded $418,653,874 for fixed-price-incentive, cost-plus-incentive-fee, cost-plus-fixed-fee modification to a previously awarded unpriced letter contract for new procurement of Trident II missile production, D5 life extension production, and D5 deployed systems support. Work is expected to be completed Sept. 30, 2022, for both base and option. The maximum dollar value of the modification, including the base items and all option items if exercised, is $1,122,936,777. Fiscal 2017 weapons procurement in the amount of $31,635,824; and United Kingdom funds in the amount of $3,619,000 are being obligated on this award, none of which will expire at the end of the current fiscal year. Subject to availability, fiscal 2018 operations and maintenance funds in the amount of $316,700,000; and United Kingdom funds in the amount of $66,699,050 will be obligated for the effort. Strategic Systems Programs, Washington, District of Columbia, is the contracting activity.
|
SYBX | Hot Stocks17:18 EDT Atlas Venture Fund IX reports 16.3% stake in Synlogic
|
OLN | Hot Stocks17:16 EDT Olin lifts Force Majeure, sees Q3 EBITDA reduced by $40M - Olin Corporation announced that it is lifting the Force Majeure declared on August 31 for all product shipments, except phenol, acetone, methyl chloride, methylene chloride and chloroform, from its Freeport, Texas facility. Olin was forced to reduce production at the facility due to supply and logistic constraints from truck, railroad and marine transportation caused by severe flooding resulting from Hurricane Harvey. Olin's Q3 adjusted EBITDA will be reduced by approximately $40M representing incremental costs to continue operations, unabsorbed fixed manufacturing costs and reduced profit from lost sales. Isolated transportation, raw material and customers' issues will continue to be experienced in both the Chlor Alkali Products and Vinyls and Epoxy segments into Q4. The impact on Q4 adjusted EBITDA is expected to be significantly less than the Q3 impact.
|
COL | Hot Stocks17:13 EDT DTN acquires Wilkens Weather Technologies from Rockwell Collins - DTN announced that it has acquired Wilkens Weather Technologies from Rockwell Collins. Wilkens Weather Technologies provides weather forecasting services to customers in the offshore/maritime industry, particularly oil and gas. Terms of the transaction were not released.
|
LNT | Hot Stocks17:07 EDT Alliant Energy announces new Upland Prairie Wind Farm - Alliant Energy's Iowa energy company continues moving toward a cleaner energy future with the start of major construction on its next wind farm in spring 2018. The company finalized an agreement with Apex Clean Energy for Upland Prairie Wind Farm. The 300-megawatt project is located in Clay and Dickinson counties in northwest Iowa. Alliant Energy received approval in 2016 to add up to 500 megawatts of wind energy. The company has requested a similar expansion from the Iowa Utilities Board again in 2017. The combined projects would represent a $1.8B investment and add up to 1,000 megawatts of new wind generation in Iowa. Together, that's enough to power up to 430,000 Iowa homes a year. The 300 megawatt wind farm will have 121 turbines and enough annual energy output for about 130,000 homes a year. Over the life of the project, there will be over $40M in local tax benefits.
|
QTRH SSNLF | Hot Stocks17:07 EDT WiLAN enters new comprehensive license agreement with Samsung - Quarterhill announced that its wholly-owned subsidiary, Wi-LAN, has entered into a new comprehensive license agreement with Samsung (SSNLF). This new license agreement expands upon the patent rights previously granted to Samsung in the wireless license agreement announced in 2013. The terms of this agreement are confidential.
|
TDW | Hot Stocks17:05 EDT Tidewater to list Series A, Series B warrants on NYSE - Tidewater announced that the company has notified the New York Stock Exchange of its intent to list its Series A Warrants and Series B Warrants with CUSIP numbers 88642R 117 and 88642R 125, respectively, on the NYSE. The Series A Warrants will have the ticker symbol "TDW WS.A" and the Series B Warrants will have the ticker symbol "TDW WS.B". Trading is expected to commence on October 5, 2017, subject to compliance at that time with applicable NYSE listing standards. As previously disclosed, the Series A Warrants and Series B Warrants were issued to holders of Tidewater's pre-emergence common stock upon the company's emergence from chapter 11 reorganization in accordance with the company's Second Amended Joint Prepackaged Chapter 11 Plan of Reorganization.
|
MYL NVS | Hot Stocks17:02 EDT Mylan announces U.S. launch of generic Gleevec Tablets - Mylan (MYL) announced the U.S. launch of Imatinib Mesylate Tablets, 100 mg and 400 mg, a generic version of Novartis's (NVS) Gleevec Tablets. Mylan received final approval from the U.S. FDA for its Abbreviated New Drug Application for this product, which has multiple indications, including for several blood cancers. Imatinib Mesylate Tablets, 100 mg and 400 mg, had U.S. sales of approximately $1.7B for the 12 months ending July 31, according to QuintilesIMS.
|
PG | Hot Stocks16:56 EDT P&G: Adding Peltz to board would 'derail' progress - The Procter & Gamble Company responded to the report issued by Institutional Shareholder Services Inc. regarding the election of directors to the P&G board at the company's Annual Meeting of Shareholders to be held on October 10, 2017. "The P&G board has been overseeing the most significant transformation in the company's history," the company said. "We have strengthened and streamlined our portfolio, simplified our organizational structure and significantly enhanced P&G's productivity. As ISS clearly recognized in its report, the changes needed to accelerate growth are already being implemented, and our results demonstrate that the plan is working. P&G today is a profoundly different and more profitable Company than it was just a few years ago. We believe ISS set too low a standard for adding an activist investor to a board and we fundamentally disagree with its conclusion. Change is not warranted when a highly engaged Board is overseeing a plan that is working. We firmly believe adding Nelson Peltz to the P&G Board would derail our progress and therefore urge shareholders to vote the BLUE Proxy Card today." Procter & Gamble's board and management team said that they strongly recommend shareholders vote "FOR" ALL of P&G's directors on the BLUE Proxy Card.
|
ORIG | Hot Stocks16:25 EDT George Economou reports 9.4% stake in Ocean Rig UDW
|
APTS | Hot Stocks16:21 EDT Preferred Apartment acquires 300-unit multifamily community in Marietta, GA - Preferred Apartment Communities announced the acquisition of a 300-unit Class A multifamily community in Marietta, Georgia constructed in 2016 called Aldridge at Town Village. "This is a brand new and attractive property that we originated a real estate loan investment on over two years ago," said Leonard A. Silverstein, the President and Chief Operating Officer for PAC. Silverstein added, "This acquisition demonstrates the success of our unique real estate loan investment program, which continues to create a tremendous pipeline of newly constructed Class A multifamily communities."
|
WWW | Hot Stocks16:16 EDT Wolverine World Wide announces sale of U.S. DoD footwear business - Wolverine World Wide announced the sale of assets associated with its United States Department of Defense contract business and the transfer of outstanding DoD contracts to Original Footwear. Original is a Tennessee-based footwear manufacturer specializing in products for the Department of Defense under the Altama brand. The company also owns Original S.W.A.T, and Ro-Search brands. This sale will improve the future viability of the Big Rapids factory operations. Original qualifies as a "small business" under Small Business Administration regulations, which allows the company access to a significant number of contracts not available to "large" corporations like Wolverine Worldwide. The sale is effective September 29. Included in this sale is Wolverine Worldwide's Big Rapids, Michigan factory, which is one of the largest producers of footwear to the United States military. Over the last several years, the Company has invested significantly in the factory and its future, through facility expansion and machinery. Original Footwear will become a footwear supplier to Wolverine Worldwide for certain products currently made in the Big Rapids factory. Wolverine will retain the Bates brand and will continue to operate the Bates civilian and military exchange business.
|
PMTS | Hot Stocks16:15 EDT CPI Card Group reaches settlement in patent litigation - CPI Card Group announced that it has reached a settlement with Gemalto S.A to resolve the two patent litigation suits pending in the U.S. District Court for the District of Colorado. Under the terms of the settlement, CPI Card Group has agreed to make a one-time payment of $750,000 in Q4. The settlement will result in the dismissal of both lawsuits with prejudice. The settlement agreement also includes a mutual covenant not to sue for a period of 18 months. CPI Card Group has denied any wrongdoing in this matter, but is settling to avoid the uncertainty, distraction, and expense of protracted litigation.
|
ORIG | Hot Stocks16:09 EDT BlueMountain Capital reports 10.9% stake in Ocean Rig UDW
|
CRAI | Hot Stocks16:09 EDT CRA International announces William Schleyer to step down from board - Charles River Associates announced that William Schleyer has informed the company of his plans to step down from CRA's board effective October 13 after nearly 10 years of service, in order to spend more time serving on non-profit boards and endeavors. Mr. Schleyer has served as a director since January 2008. Most recently, he was a member and Chair of the Compensation Committee.
|
MNR | Hot Stocks16:08 EDT Monmouth Real Estate acquires Ohio industrial building - Monmouth Real Estate Investment Corporation announced the acquisition of a brand new 219,765 square foot industrial building located at 4651 Prosper Drive, Stow, OH at a purchase price of $19.5M. The property is net-leased for 10 years to Mickey Thompson Performance Tires and Wheels and is guaranteed by Cooper Tire and Rubber Company, a Delaware Corporation. The building is situated on approximately 15.4 acres and is expandable by 50,000 square feet.
|
FNWB | Hot Stocks16:06 EDT First Northwest Bancorp adopts stock repurchase plan - First Northwest Bancorp announced that its Board of Directors authorized the repurchase of up to 10% of the company's common stock, or approximately 1,166,659 shares. The company recently repurchased 1,162,100 shares, or approximately 8.9%, of its common stock through a repurchase program, which ended on September 27.
|
JNCE | Hot Stocks16:03 EDT Partner Fund Management reports 5.4% passive stake in Jounce Therapeutics
|
SO | Hot Stocks15:19 EDT Georgia Power names Xia Liu executive VP, CFO - The Georgia Power's board has elected Xia Liu as executive VP, CFO and treasurer, effective October 1. In her new role, Liu will be responsible for overseeing the company's accounting and financial functions. Liu began her career at Southern Company in 1998 and has served in nearly a dozen roles with increasing responsibility, including senior VP of finance for Southern Company Services and treasurer for Southern Company, VP of finance for Southern Company Services and assistant treasurer for Southern Company, director of financial and corporate planning and assistant treasurer for Alabama Power, fuels environmental and compliance manager for Southern Generation, and others.
|
MDXG | Hot Stocks15:11 EDT MiMedx says document exposes short sellers' 'false and misleading' statements - MiMedx announced that it has published a document on the company's website "exposing the false and misleading information distributed by Viceroy Research and Aurelius Value in their articles on MiMedx." CEO Parker "Pete" Petit stated, "I encourage all MiMedx shareholders to thoroughly review and consider our document posted today on our website. As you are aware, MiMedx and all other public companies are governed by federal regulations prohibiting the dissemination of false and misleading information about the Company; unfortunately, organizations like Viceroy Research and Aurelius Value are not held to those standards and often such organizations have little to no accountability for the misinformation they publish. Both the Viceroy Research report and the Aurelius Value report indicate that either they are short in MDXG, or that the reader should assume they are short in MDXG."
|
ICE... | Hot Stocks13:39 EDT The Intersection: Crypto and Wall Street This Week - As bitcoin, ethereum and other cryptocurrencies get increasing attention from investors, Wall Street and its traditional banks continue to adjust to the shift. Catch up on this week's top stories highlighting the intersection of these old guard and new school areas of finance with this recap compiled by The Fly: 1. SOUTH KOREA JOINS CRACKDOWN: South Korea's Financial Services Commission plans to ramp up inspections of digital currency exchanges and has banned initial coin offerings citing criminal cases involving cryptocurrencies, according to The Wall Street Journal. The regulator is also said to be banning coin margin transactions, with penalties for violations will be "stern." The move comes as China, the U.S. and Singapore all take steps to tighten regulations on the digital currencies amid cybersecurity and fraud risks. 2. ECB CAN'T REGULATE, SEC NOT EQUIPPED: European Central Bank president Mario Draghi said that "it would actually not be in our powers to prohibit and regulate" digital currencies when asked whether the ECB plans to issue a regulatory framework or an all-out cryptocurrency ban. He added the bank has yet to discuss the impact of the currencies, but a primary concern surrounding the subject is cybersecurity. Meanwhile, the U.S. Securities and Exchange Commission announced Monday it is establishing a Cyber Unit focusing on digital events, such as hacks and dealings regarding ICOs and distributed ledgers like blockchain. However, on Thursday, former SEC chairman Arthur Levitt said he believes the regulator is not equipped to take on bitcoin. "They have too many other issues that they are dealing with now that they don't want to take on something as complex from a regulatory point of view as bitcoin is," he said. Levitt's comments came after Grayscale Investments said Intercontinental Exchange's (ICE) NYSE Arca platform dropped a bid with the SEC to list its Bitcoin Investment Trust. Grayscale, the fund's sponsor, noted that the SEC has already denied two similar applications and said it "does not believe there have been enough regulatory developments" to prompt the approval. 3. HEDGE FUNDS: Former Fortress Investment Group (FIG) manager Mike Novogratz is planning to start a $500M hedge fund, called Galaxy Digital Assets Fund, to invest in cryptocurrencies, ICOs and related businesses. "This is going to be the largest bubble of our lifetimes," he said in an interview on Tuesday. "Prices are going to get way ahead of where they should be. You can make a whole lot of money on the way up, and we plan on it." Novogratz, who plans to put up $150M and raise the remaining funds, said the space needs more regulation amid fraudulent schemes but estimates he has roughly 20% of his net worth in digital assets. His move comes as many new cryptocurrency funds emerge, with U.K. research firm Autonomous NEXT reporting 68 crypto hedge funds using strategies ranging from ICOs to holding bitcoin and other digital currencies. 4. MORE THAN A FAD: Morgan Stanley (MS) CEO James Gorman said bitcoin is "certainly something more than just a fad," after JPMorgan (JPM) CEO Jamie Dimon called the cryptocurrency a "fraud." At a Wednesday event, Gorman said, "I haven't invested in it...it's obviously highly speculative but it's not something that's inherently bad. It's a natural consequence of the whole blockchain technology." Meanwhile, "The Wolf of Wall Street" Jordan Belfort echoed Dimon's remarks, saying bitcoin is a fraud in an interview on Wednesday. Belfort, who said he would never buy bitcoin himself, expects a central bank to set up its own cryptocurrency "and that's what will take hold." 5. OVERSTOCK: DA Davidson analyst Tom Forte raised his price target to $36 from $28 on Overstock.com (OSTK) on Thursday after the company announced that it was launching an Alternative Trading System for trading tokens from ICOs. Following the deal, the analyst estimates that the company's Medici Ventures subsidiary is worth $11 per share, up from his previous $2 per share estimate. The analyst warns that regulations on digital tokens could change, but he keeps a Buy rating on the stock. 6. OTHER BITCOIN PLAYS: In prior research, Jefferies' analyst Mark Lipacis told investors that he estimates cryptocurrency revenues accounted for about 3% of quarterly sales for Advanced Micro Devices (AMD) and about 10% for Nvidia (NVDA) in the second quarter. PRICE ACTION: As of time of writing, Bitcoin is up about 17% this week, or $600, to $4,185 in U.S. dollars. Meanwhile, AMD shares dropped about 4% to $12.73 this week and Nvidia is little changed on a weekly basis. Bitcoin Investment Trust (GBTC) rose 0.4% this week to $717.20. WANT BITCOIN NEWS ALERTS?: To receive alerts on stories relating to bitcoin and other cryptocurrencies, Fly subscribers can enter "Bitcoin" into the "Add symbols" box of their portfolios.
|
FLIC | Hot Stocks13:32 EDT First Long Island raises quarterly dividend 7.1% to 15c per share - The First of Long Island Corporation announced the declaration of a Q3 cash dividend in the amount of 15c per share. This represents a 7.1% increase over the split-adjusted dividend declared in the same quarter last year. The dividend will be paid on October 20 to shareholders of record on October 11.
|
SRPT | Hot Stocks13:25 EDT Sarepta says Exondys 51 patient deaths were 'natural disease progression' - In a statement to The Fly, Sarepta head of investor relations Ian Estepan said, "Duchenne muscular dystrophy is a 100% fatal disease that causes severe progressive muscle loss and premature death in the late-teens to 20s typically due to respiratory or cardiac complications. The deaths reported by the FDA FAERS database were individuals in their late 20s and are consistent with the natural disease progression. The events are not believed to be related to Exondys 51 and the safety profile of the drug remains consistent with previous disclosures. Our heartfelt condolences go out to the families of these young adults and the community at large."
|
RDY SNY | Hot Stocks13:22 EDT Dr. Reddy's announces launch of sevelamer carbonate tablets in the U.S. - Dr. Reddy's Laboratories (RDY) announced that it has launched Sevelamer Carbonate Tablets, 800 mg, a therapeutic equivalent generic version of Renvela Tablets, approved by the U.S. Food and Drug Administration. The Renvela brand and generic had U.S. sales of approximately $1.88B MAT for the most recent twelve months ending in July 2017 according to IMS Health. Dr. Reddy's Sevelamer Carbonate Tablets, 800 mg are available in the bottle count size of 270 tablets. Renvela is a trademark of Genzyme Corporation (SNY).
|
NDN | Hot Stocks13:20 EDT 99c Only Stores statement on credit rating, progress in term loan amendment - 99 Cents Only Stores issued the following statement from its President and CEO, Geoffrey Covert, regarding Standard & Poor's recent lowering of the company's credit rating from CCC+ to CC and the company's continued progress in its term loan amendment and extension process: ""On September 19, 2017, we announced that we elected to launch a proposed amendment to our existing term loan facility, which would among other things, extend the maturity date of our term loan facility by three years from January 2019 to January 2022 and reduce our cash interest obligations thereunder. Our election to proactively move forward with this process is an opportunistic one and came after productive conversations with our equity sponsors, as well as several of our largest term loan lenders. We continue to make progress with the term loan lenders and remain optimistic of completing the proposed amendment in an expeditious manner. Earlier today, Standard & Poor's lowered our credit rating from CCC+ to CC, based entirely on our proposed extension of maturity to our term facility. We view the rating change as a technical response to our refinancing plans. We believe the fundamentals of our company remain strong and we continue to be optimistic regarding our sales and adjusted EBITDA momentum. We expect the ratings changes to be temporary and that our ratings would be raised to appropriate levels shortly after the close of the proposed transaction, reflecting ongoing risk at that time. In addition, this rating change is not expected to impact our day to day business or our ability to meet future obligations. Importantly, we do not believe the ratings change reflects 99 Cents Only Stores' operational performance, which has continued to improve. During the second quarter of fiscal 2018, same-store sales growth was 9.0% compared to the prior year, the sixth consecutive quarter of flat or positive growth and the third consecutive quarter of high single-digit same-store sales growth. In addition, our latest twelve months Adjusted EBITDA of $58.4M is more than two times higher than the same time last year. Finally, on-hand inventory of $189M is down approximately $77M from the third quarter of fiscal 2016."
|
BHGE | Hot Stocks13:02 EDT Baker Hughes reports U.S. rig count up 5 to 940 rigs - Baker Hughes reports that the U.S. rig count is up 5 rigs from last week to 940, with oil rigs up 6 to 750, gas rigs down 1 to 189, and miscellaneous rigs unchanged at 1. The U.S. Rig Count is up 418 rigs from last year's count of 522, with oil rigs up 325, gas rigs up 93, and miscellaneous rigs unchanged at 1. The U.S. Offshore Rig Count is up 3 rigs from last week to 22 and unchanged year-over-year. The Canada Rig Count is down 7 rigs from last week to 213, with oil rigs down 9 to 113 and gas rigs up 2 to 100. The Canada Rig Count is up 51 rigs from last year's count of 162, with oil rigs up 29 and gas rigs up 22.
|
PRXL | Hot Stocks13:00 EDT Pamplona Capital completes acquisition of Parexel - PAREXEL International announced that Pamplona Capital Management has completed its acquisition of PAREXEL. Pamplona acquired all outstanding shares of PAREXEL for $88.10 per share in cash. The transaction was approved overwhelmingly by stockholders on September 15, with more than 98% of votes cast in favor. PAREXEL stock will stop trading at the close of business today. Josef von Rickenbach will continue to serve as CEO. Dr. Jeremy Gelber, Partner of Pamplona Capital Management, will serve on the Board of Directors.
|
FE | Hot Stocks12:50 EDT FirstEnergy CEO 'commends' proposal to support U.S. baseload generating plants - FirstEnergy president and CEO Charles E. Jones issued a statement regarding the Department of Energy's proposal to help prevent additional premature closures of U.S. baseload generating facilities: "We commend Secretary Perry and the Department of Energy for recognizing the importance of a reliable, resilient electric grid for American families and our nation's economy. Correcting the faulty market conditions and keeping essential baseload generating plants operating will help ensure customers continue to receive safe, reliable and affordable supplies of electricity while maintaining the security of the electricity grid. We look forward to final action by the Federal Energy Regulatory Commission as soon as possible."
|
NCS USG | Hot Stocks12:43 EDT NCI Building chairman Chambers to step down, Metcalf named successor - NCI Building Systems (NCS) announced Norman C. Chambers, chairman of the board since 2008, will step down as chairman of the board of directors effective January 1, 2018. The board of directors has selected James S. Metcalf to succeed Chambers as chairman of the board of directors and chairman of the executive committee of the company, effective January 2, 2018. Metcalf recently retired from a thirty-six year career at USG Corporation (USG), where he served as chairman, CEO and president from 2011 to 2016.
|
COP | Hot Stocks12:36 EDT ConocoPhillips completes sale of Texas Panhandle assets - ConocoPhillips completed its previously announced transaction with an undisclosed buyer to sell its Texas Panhandle assets for $184M, plus net customary adjustments. Proceeds from this transaction will be used for general corporate purposes. The company's 2017 production guidance already reflects the impact of this sale.
|
VLKAY | Hot Stocks12:29 EDT Most new 2018 VW cars in the U.S. to come with People First Warranty - Volkswagen said in a statement that, for the 2018 model year, most new VW vehicles in the United States will come with the People First Warranty, a six-year or 72,000-mile, whichever occurs first, bumper-to-bumper New Vehicle Limited Warranty, which can be transferred to subsequent owners throughout its duration. "Volkswagen has always been 'the people's car,' and with the People First Warranty, we're putting our customers first," said Hinrich J. Woebcken, President and Chief Executive Officer of Volkswagen Group of America. "By bringing the right cars, at the right time and making the offer very competitive, we believe we're in the position to grow in the US market." First introduced for the all-new 2018 Atlas and Tiguan, the People First Warranty now covers additional 2018 VW models: Beetle, Beetle Convertible, Golf, Golf Alltrack, Golf GTI, Golf R, and Golf SportWagen, Jetta and Passat. Reference Link
|
CMCSA... | Hot Stocks12:22 EDT Box Office Battle: 'Kingsman' expected to hold off 'American Made' - 21st Century Fox's (FOX, FOXA) "Kingsman: The Golden Circle," the sequel to 2015 action film "Kingsman," is expected to remain atop the box office for the second week, with a domestic gross of $19M-$20M. Time Warner's (TWX) Warner Bros. and New Line Cinema's horror film "It," which has already grossed $500M worldwide, making it the top horror film of all time, is expected to earn around $17M in its fourth weekend at theaters. Opening this weekend is Comcast (CMCSA, CMCSK) subsidiary Universal's crime thriller "American Made," starring Tom Cruise and Jesse Plemons, which is expected to earn $16M-$17M at just over 3,000 theaters. Warner Animation Group's "The LEGO Ninjago Movie," the third film in the animated LEGO franchise, is expected to earn $11M-$12M in its second weekend at theaters. Other publicly traded companies in filmmaking include Disney (DIS), Lionsgate (LGF.A, LGF.B), Sony (SNE), and Viacom (VIA, VIAB).
|
ALR | Hot Stocks12:14 EDT Alere says DOJ closes investigation into sales practices, says no action taken - Alere announced the U.S. Department of Justice has closed the previously announced investigation into, among other things, sales, sales practices and dealings with certain third parties, without taking any action against Alere. The DOJ investigation primarily involved matters occurring at foreign subsidiaries previously acquired by the company. "We are pleased that this matter has been closed with no action taken against Alere," the company said.
|
IONS | Hot Stocks12:14 EDT Ionis Pharmaceuticals says Spinraza deaths disease related, not drug related - In a statement to The Fly, Ionis Pharmaceuticals spokesman Wade Walke provided a screenshot of the FAERS database and said, "Initial reports regarding deaths reported in the FAERS database indicated that deaths were due to the SPINRAZA treatment. This is not the case. [...] The reason for death in all cases is disease related and not drug related."
|
HSBC | Hot Stocks12:05 EDT HSBC fined $175M for unsafe and unsound practices in foreign exchange trading - The Federal Reserve board announced that it has fined HSBC $175M for the firm's unsafe and unsound practices in its foreign exchange trading business. The board levied the fine for deficiencies in HSBC's oversight of, and internal controls over, FX traders who buy and sell U.S. dollars and foreign currencies for the firm's own accounts and for customers. The firm failed to detect and address its traders misusing confidential customer information, as well as using electronic chatrooms to communicate with competitors about their trading positions. The board's order requires HSBC to improve its controls and compliance risk management concerning the firm's foreign exchange trading.
|
VMC | Hot Stocks11:51 EDT Vulcan Materials reports termination of agreement with Polaris Materials - Vulcan Materials Company issued the following comment in response to the announcement by Polaris Materials Corporation that Polaris has terminated its previously announced agreement to be acquired by Vulcan. Polaris indicated it has terminated the agreement because its Board of Directors has accepted a Superior Proposal as defined in the agreement with Vulcan. "Vulcan is a disciplined buyer, and we believe that our prior agreement to acquire Polaris for C$2.79 per share represented full and fair value for the company," said Vulcan's Chairman and CEO Tom Hill. "Vulcan remains well positioned for long-term growth and we look forward to continuing to seek opportunities to further enhance shareholder value." Vulcan noted that under the terms of its agreement with Polaris, Vulcan has received a C$10M termination fee from Polaris.
|
USCR VMC | Hot Stocks11:50 EDT U.S. Concrete to acquire Polaris Materials for C$309M - U.S. Concrete (USCR) announced that it has entered into an arrangement agreement with Polaris Materials, pursuant to which U.S. Concrete will acquire all the issued and outstanding common shares of Polaris for C$3.40 per share in cash by way of a statutory plan of arrangement. The price per share implies an aggregate fully diluted equity value for Polaris of approximately C$309M. Additionally, Polaris has terminated the previously announced arrangement agreement between Polaris, Vulcan Materials (VMC) and a wholly-owned subsidiary of Vulcan dated August 25. The transaction represents a 22% premium to the C$2.79 per share transaction price pursuant to the terminated Vulcan Agreement. Completion of the USCR Arrangement is subject to customary closing conditions, including approval of Affected Securityholders and court approval, and is expected to close in the fourth quarter of 2017. "We believe that Polaris is an ideal strategic fit and enables a replication in California of our vertically integrated business model that we successfully operate in New York" said U.S. Concrete's President, CEO and Vice Chairman William J. Sandbrook. "The acquisition of Polaris will provide U.S. Concrete with long-term, high quality aggregate reserves and is expected to deliver meaningful synergies and strengthen the Company's strategic position in the highly attractive, aggregate supply-constrained Californian markets. Following completion of the acquisition, U.S. Concrete expects to have the capability to self-supply a large majority of its market leading ready-mixed concrete operations' aggregate requirements in Northern California and to drive increased production volumes at Polaris' Orca Quarry. The acquisition also provides us an entrance into Southern California through the Polaris-operated Long Beach Terminal."
|
IONS... | Hot Stocks11:46 EDT FDA says 'important to note context and limitations' of FAERS data - The FDA's Office of Media Affairs said via Twitter, Goal of dashboard is access but important to note context and limitations for FAERS data: go.usa.gov/xnqcK."
|
AAPL | Hot Stocks11:45 EDT NAB urges Apple to activate feature to support FM radio - In response to Apple's statement regarding FCC Chairman Ajit Pai supporting the activation of FM chips on iPhones, the following statement can be attributed to the National Association of Broadcasters, NAB, Executive Vice President of Communications Dennis Wharton: "Since 2012 NAB has commissioned quarterly 'tear down' reports from ABI Research on a wide variety of Smartphones to discover their capabilities. ABI's analysis reveals that every Apple iPhone built during that time, including the iPhone 7, has a chipset that includes support for FM radio. Apple also continues to sell an iPhone 6S with an FM chip that is not activated, and there are nearly 100 million iPhones in the marketplace with a deactivated FM chip. "Like FCC Chairman Pai, we encourage Apple to activate this feature on their future handsets so Americans can have access to lifesaving information during emergency situations, something that many local radio stations provide. We welcome the opportunity to work with Apple to make that happen."
|
SO | Hot Stocks11:32 EDT Georgia Power receives additional $1.67B loan guarantee for new Vogtle units - Georgia Power, a subsidiary of Southern Company, announced that it has reached an agreement with the U.S. Department of Energy, or DOE, for a conditional commitment of approximately $1.67B in additional loan guarantees for the Plant Vogtle nuclear expansion project near Waynesboro, Georgia. Georgia Power had previously secured loan guarantees of $3.46B for the construction of Vogtle units 3 and 4, the first to be built in the U.S. in more than 30 years. With a total of more than $5B in anticipated DOE loan guarantees, Georgia Power expects to be able to provide more than $500M in present-value benefits to its customers. Georgia Power owns 45.7% of the new units, with the project's other Georgia-based co-owners including Oglethorpe Power, MEAG Power and Dalton Utilities. "We thank the DOE for their support and commitment to the Vogtle 3 and 4 project," said Paul Bowers, chairman, president and CEO of Georgia Power. "From the outset, Georgia Power and the project co-owners have worked to minimize the impact of the project on our customers' bills and these additional loan guarantees will help us continue to reduce our financing costs."
|
RTN... | Hot Stocks11:17 EDT Raytheon, Northrop seen boosted by missile defense spending hike - Threats by North Korea to launch missiles at the U.S. will spur a significant increase in America's spending on missile defense, predicted Deutsche Bank. Among the companies best positioned to benefit from this trend are Raytheon (RTN), Lockheed Martin (LMT), Northrup Grumman (NOC), and Boeing (BA), an analyst at the firm stated. MISSILE DEFENSE SPENDING: The government is set to release a Missile Defense Review within the next few months, wrote Deutsche Bank analyst Myles Walton. Moreover, during the last decade U.S. spending on missile defense has dropped nearly 25% in real dollar terms, Walton noted. Rising tensions overseas could spur "solid growth" in overseas markets, the analyst believes. COMPANY EXPOSURE: Raytheon is the most exposed to missile defense, but Northrop Grumman is well-positioned to have the most growth in the category, partly due to its acquisition of Orbital ATK (OA) and the U.S. government's increased investments in space-based missile defense, Walton wrote. The analyst believes that Lockheed Martin should also benefit from increased spending on missile defense, but he identified Northrop Grumman as his favorite name in the sector. RATINGS, TARGETS: Walton upgraded Raytheon to Buy from Hold and raised his price target for the shares to $210 from $180. He also raised his price target on Northrop to $325 from $285 and on Lockheed to $340 from $305. PRICE ACTION: In morning trading, Raytheon added 0.4% to about $185 per share, Northrop was flat at $285, Lockheed Martin was flat at $309 and Boeing was unchanged near $254 per share.
|
LLY | Hot Stocks11:00 EDT Eli Lilly names new CFO, head of R&D in management shakeup - Shares of Eli Lilly and Company (LLY) are in focus this morning after the company named a new chief financial officer and replaced the head of its research and development unit, among other changes. MANAGEMENT CHANGES: Eli Lilly announced this morning that current CFO, Derica Rice, will retire in June and that Josh Smiley has been promoted to senior vice president and CFO and will become a member of Lilly's executive committee, effective January 1, 2018. Dan Skovronsky, a senior vice president at the company, will become SVP for science and technology and president of Lilly Research Labs on June 1, 2018, succeeding Jan Lunberg, who will retire at the end of May. The company also announced that Myles O'Neill will become SVP and president of manufacturing operations beginning January 1, replacing Maria Crowe, who is retiring in December. Commenting on the management shakeup, Chairman and CEO David Ricks said that "joining our executive team are individuals who have the experience, expertise and leadership skills to build on our momentum of innovation driven volume growth. Importantly, this team will help us maintain focus as we work to bring forward new medicines in diabetes, cancer, immunology, neurodegeneration and pain and change the path of serious disease." WHAT'S NOTABLE: Earlier this month, Eli Lilly said it would cut about 3,500 jobs around the world, resulting in annual savings of about $500M beginning in 2018. The company expects most of the cuts to come from a voluntary early-retirement program it is offering in the U.S. It is also closing a plant in Larchwood, Iowa, the research and development office in Bridgewater, New Jersey and the Lilly China Research and Development Center in Shanghai, China. Lilly expects charges of about $1.2B before tax, or 80c per share after tax. The initiatives are part of a broad productivity plan to improve its cost structure, particularly fixed costs, the company said at the time. PRICE ACTION: Eli Lilly is fractionally lower in morning trading. Shares are up about 15% year-to-date.
|
RTNB | Hot Stocks10:54 EDT Nasdaq halts root9B Holdings for additional information - Nasdaq announced that trading was halted today in root9B Holdings at 10:01:25 ET for "additional information requested" from the company at a last sale price of $2.005. Trading will remain halted until root9B has fully satisfied Nasdaq's request for additional information.
|
KANG | Hot Stocks10:49 EDT Fosun International reports 5.02% passive stake in iKang Healthcare
|
IONS... | Hot Stocks10:48 EDT Ionis, Sarepta dip in wake of FDA adverse event search change - Shares of Ionis Pharmaceuticals (IONS) and Sarepta Therapeutics (SRPT) have both slid this morning as the new, more user-searchable FDA Adverse Events Reporting System has driven attention, which some argue is misplaced, to reported deaths seen in patients using the companies' therapies. FDA SYSTEM UPDATE: Yesterday, the FDA announced its launch of a new user-friendly search tool that improves access to data on adverse events associated with drug and biologic products through the FDA's Adverse Event Reporting System, or FAERS. In its announcement, the FDA stated: "While the FAERS dashboard now offers stakeholders many more ways of searching for and organizing data on adverse events reported to the FDA for many drug and biologic products, there remain limitations to the data...while FAERS contains reports on a particular drug or biologic, this does not mean that the drug or biologic caused the adverse event." Other limitations include duplicate and incomplete reports are in the system, the information in reports has not been verified and rates of occurrence cannot be established with reports, the FDA adds. FAERS REPORTS PASSED AROUND: The early weakness in shares of Ionis was attributed to a link being passed around by traders that shows nine patients have died while taking Spinraza. Ionis partners with Biogen (BIIB) on the spinal muscular atrophy drug. Similarly, early weakness in Sarepta was attributed to a link showing patients taking Exondys 51 have had 11 serious cases, with three dying. EXPERTS ADVISE CAUTION: Baird biotechnology analyst Brian Skorney tweeted this morning, "This is what happens when FAERS becomes easily searchable. Folks who haven't been looking at it for years don't understand the data." STAT's Adam Feuerstein has also tweeted, "Today's pastime seems to be searching FDA's FAERS database and tweeting side effects/deaths out of context." PRICE ACTION: In early trading, Ionis shares remain about 5% lower, though this is off the stock's worst levels of the session. Meanwhile, Sarepta is near its session lows with a slide of over 6%.
|
JBHT... | Hot Stocks10:29 EDT Stifel names truckers to buy ahead of 'mother of all capacity shortages' - Research firm Stifel upgraded three trucking companies - J.B. Hunt (JBHT), Heartland Express (HTLD), and USA Truck (USAK) - to Buy from Hold, saying that the sector is poised to benefit from multiple positive catalysts in the next year. POSITIVE CATALYSTS: The trucking "spot market is red hot," partly due to the expected launch in late 2017 or early 2018 of a rule which will require all truck drivers to use electronic logging devices, according to Stifel analyst John Larkin. Moreover, FEMA's use of trucks to rush supply to areas hurt by the recent hurricanes has transformed the freight market "from modestly positive to strongly positive," the analyst stated. Other catalysts include the need to rebuild structures damaged by the storms and the upcoming holiday shopping season, Larkin stated. Taken together, these trends should produce "a prolonged period of elevated demand, strong spot rates, and sizable mid- to high-single digit contract price hikes," predicted Larkin. He estimated that truckload prices would rise 4.5%-8.5% next year during what he calls the "mother of all capacity shortages" Additionally, the industry could see a significant amount of M&A next year, as borrowing costs remain low and labor shortages are making it difficult for companies to generate organic growth, the analyst stated. J.B. HUNT: The company's high leverage to intermodal gives it an advantage in the "mother of all capacity shortages" environment, as intermodal is the best way to overcome driver shortages, according to Larkin. The analyst added that the company's dedicated unit will benefit from its ability to perform many difficult and specialized tasks. He raised his price target on the stock to $125 from $91. HEARTLAND EXPRESS: Heartland is "a great operating company," and its recent acquisitions will enable it to lower its costs, Larkin believes. Moreover, the analyst thinks that the company's balance sheet "remains strong." He raised his price target on the shares to $28 from $22. USA TRUCK: The company has had difficulty turning a profit, but its new management team is adept and is "in a position to be fully supported by a much better operating environment for truckload carriers," according to Larkin. He raised his price target on the shares to $15 from $9. PRICE ACTION: In morning trading, JB Hunt rose 1.1% to $110.10, Heartland Express climbed over 5% to $24.59 and USA Truck advanced 9% to $14 per share.
|
IONS SRPT | Hot Stocks10:17 EDT Baird analyst says FDA adverse events data not being understood - With shares of Ionis Pharmaceuticals (IONS) and Sarepta Therapeutics (SRPT) moving lower amid concerns over patient deaths, Baird biotechnology analyst Brian Skorney tweeted, "This is what happens when FAERS becomes easily searchable. Folks who haven't been looking at it for years don't understand the data." The FDA recently changed the search functionality for its Adverse Event Reporting System, or FAERS.
|
NVO | Hot Stocks10:13 EDT Novo Nordisk announces FDA approval of fast-acting mealtime insulin Fiasp - Novo Nordisk announced that the US Food and Drug Administration has approved Fiasp, a new fast-acting mealtime insulin, for the treatment of adults with diabetes. Fiasp is an innovative formulation of insulin aspart, NovoLog, developed with the aim of obtaining pharmacokinetic and pharmacodynamic properties that more closely match the natural physiological insulin mealtime response of a person without diabetes, the company noted.
|
IONS SRPT | Hot Stocks10:10 EDT STAT's Feuerstein says deaths in database taken 'out of context' - STAT's Adam Feuerstein just tweeted, "Today's pastime seems to be searching FDA's FAERS database and tweeting side effects/deaths out of context. $IONS $SRPT." The early moves lower in shares of Ionis Pharmaceuticals (IONS) and Sarepta Therapeutics (SRPT) are being attributed to concerns over patient deaths.
|
SRPT IONS | Hot Stocks10:06 EDT Sarepta weakness attributed to concern over patient deaths - The early weakness in Sarepta Therapeutics (SRPT), similar to Ionis Pharmaceuticals (IONS), is being attributed to a link showing patients taking Exondys 51 have had 11 serious cases, with three dying. The FDA recently changed the search functionality for its Adverse Event Reporting System, or FAERS, which could be generating the links being passed around by traders. It is not clear whether the deaths have been previously disclosed. Shares of Sarepta are down 4%, or $1.74, to $45.42 in early trading.
|
IONS BIIB | Hot Stocks10:00 EDT Ionis weakness attributed to concerns over patient deaths - The early weakness in shares of Ionis Pharmaceuticals (IONS) is being attributed to a link being passed around by traders that shows nine patients have died while taking Spinraza. Ionis partners with Biogen on the spinal muscular atrophy drug. The link has not been verified. Shares of Ionis are down 5%, or $2.76, to $49.85 in early trading. Biogen is down $1.24 to $308.76. The FDA just recently updated the searching functions for its Adverse Event Reporting System, or FAERS, The Fly notes. Reference Link
|
ZGNX GWPH | Hot Stocks09:49 EDT Zogenix skyrockets after successful trial for epilepsy drug - Shares of Zogenix (ZGNX), a pharmaceutical company engaged in developing and commercializing central nervous system therapies, surged in early trading after the company said its epilepsy drug met its primary endpoint in a late-stage study. WHAT'S NEW: This morning, Zogenix reported that ZX008 was shown to be superior compared to placebo in its 119-subject Phase 3 clinical trial assessing the drug in patients with a rare and severe form of epilepsy called Dravet syndrome. According to the company, the higher of two ZX008 doses reduced average monthly seizure activity by nearly 64% percent compared to placebo, achieving the primary endpoint of the study. The company also said that that ZX008 0.8 mg/kg/day demonstrated statistically significant improvements versus placebo in all key secondary measures, including the proportion of patients with clinically meaningful reductions in seizure frequency and longest seizure-free interval. The median percent reduction in monthly convulsive seizure frequency was 72.4% among ZX008 0.8 mg/kg/day patients compared to 17.4% in placebo patients, the company said. Joseph Sullivan, director of the Pediatric Epilepsy Center in UCSF Benioff Children's Hospital San Francisco, and Principal Investigator of Study 1 in the U.S., commented that these results are "truly exciting and demonstrate, in a large multicenter controlled trial, the impressive efficacy of low-dose fenfluramine for patients with Dravet syndrome. If approved, ZX008 could play an important role in treating this devastating condition." The company said it expects to report data from a second Phase 3 trial in the first half of next year and remained on track to submit regulatory approvals for the drug in the U.S. and Europe in the second half of 2018. WHAT'S NOTABLE: Adam Feuerstein, a senior biotech writer at STAT News, noted that making comparisons of drugs across different trials is difficult, but noted that GW Pharmaceuticals' (GWPH) epidiolex, a cannabidiol-based epilepsy drug, reduced seizure activity in its Phase 3 study by a placebo-adjusted 26%. 'BEST CASE' FOR ZOGENIX: Leerink analyst Paul Matteis said in a post-announcement note to clients that the top-line results for the ZX008 study in Dravet Syndrome reported by Zogenix look like a "best case scenario" for the company, noting that the trial not only hit its endpoint but the magnitude of clinical benefit was better than expected. The analyst, who has an Outperform rating on Zogenix, noted that "the magnitude of clinical benefit was better than we expected, and in the ballpark of prior compassionate use studies that conveyed an unprecedented level of benefit." PRICE ACTION: In early trading, Zogenix skyrocketed 140% to $30.80. Meanwhile, GW Pharmaceuticals shares trading in New York dropped 10% to $101.01.
|
PENN... | Hot Stocks09:31 EDT Nevada reports August statewide gaming win up 14.9% to $989.51M - Nevada reports Las Vegas Strip August gaming win up 21.35% to $545.54M. Publicly traded companies in the casino space include Boyd Gaming (BYD), Caesars (CZR), Las Vegas Sands (LVS), MGM Resorts (MGM), Penn National (PENN) and Wynn Resorts (WYNN).
|
AAAP | Hot Stocks09:26 EDT Advanced Accelerator announces EC approval of lutetium - Advanced Accelerator Applications announced that the European Commission, or EC, has approved the marketing authorization of lutetium oxodotreotide for "the treatment of unresectable or metastatic, progressive, well differentiated, somatostatin receptor positive gastroenteropancreatic neuroendocrine tumors in adults." This approval allows for the marketing of lutetium oxodotreotide in all 28 European Union member states, as well as Iceland, Norway and Liechtenstein.
|
INSY | Hot Stocks09:24 EDT Insys Therapeutics files NDA for buprenorphine sublingual spray with FDA - INSYS Therapeutics announced today that it filed a New Drug Application, or NDA, for a novel formulation of buprenorphine as a sublingual spray for the management of moderate-to-severe acute pain with the FDA.
|
SGH... | Hot Stocks09:23 EDT On The Fly: Pre-market Movers - UP AFTER EARNINGS: Smart Global (SGH), up 13.3%... Tyson Foods (TSN), up 4.7%... KB Home (KBH), up 4.2%. ALSO HIGHER: Zogenix (ZGNX), up 147.4% after its Phase 3 trial of ZX008 met the primary endpoint. Aehr Test Systems (AEHR), up 19.3% after it received follow-on orders for its FOX-XP Test and Burin-in Solution. LOWER: GW Pharmaceuticals (GWPH), down 13.1% after Zogenix ZX008 trial met its primary endpoint... Scana (SCG), down 2.9% after being downgraded to Sell from Hold at Williams Capital.
|
ABT ALR | Hot Stocks09:21 EDT Abbott acquisition of Alere set to close on October 3 - Abbott (ABT) announced it intends to close the acquisition of Alere (ALR) on Tuesday, October 3. The announcement follows receipt of all regulatory clearances necessary for closing.
|
TRNO | Hot Stocks09:18 EDT Terreno Realty acquires Fremont, California property for $7.3M - Terreno Realty Corporation acquired an industrial property located in Fremont, California on September 28 for a purchase price of approximately $7.3M. The property consists of one industrial distribution building containing approximately 41,000 square feet on 2.1 acres. The property is at 45861 Hotchkiss Street, between Interstates 880 and 680 and is vacant. After renovation, the property will provide four dock-high and two grade-level loading positions and parking for 112 cars. The estimated stabilized cap rate of the property is 5.2%.
|
DISH NFLX | Hot Stocks09:09 EDT Dish to offer whole-home 4K Netflix experience - DISH (DISH) is now the first major U.S. pay-TV provider to offer a whole-home 4K Netflix (NFLX) experience. After offering Netflix Ultra HD titles on its Hopper 3 DVR since April 2016, the company added the app to its 4K Joey client. Now DISH customers have the ability to stream the robust catalog of Ultra HD TV shows and movies on Netflix in multiple rooms throughout the home. When connected to a Hopper 3, DISH's 4K Joey provides similar TV functionality to other rooms in the home. Hopper 3 supports up to six 4K Joeys simultaneously, powering a total of seven 4K TVs at one time. DISH customers must subscribe to Netflix's $11.99 per month subscription plan and have a 4K-compatible television to access this Ultra HD content on Hopper 3 and 4K Joey.
|
PEGI | Hot Stocks09:09 EDT Pattern Energy backs FY17 CAFD view $140M-$165M, cuts Q3 CAFD outlook - Pattern Energy is reaffirming its targeted annual cash available for distribution for 2017 range of $140M-$165M. Pattern Energy is not aware of any direct effect the natural disaster events experienced during the third quarter had on general wind levels across North America. The reaffirmed 2017 CAFD range assumes long-term average proportionate production of the fleet for the remainder of 2017 and a potential adverse impact of any extended electric grid outage in Puerto Rico during the fourth quarter of 2017. The risks to the company remain the same as reflected in its prior financial guidance for 2017. Variability in wind conditions causes the company's project revenues and other financial measures to vary from period to period. The company expected CAFD of $12M-$14M for the third quarter of 2017. Based primarily on the wind conditions that were below the long-term average experienced during the third quarter of 2017, Pattern Energy now expects CAFD in a range of $5M-$11M in the third quarter of 2017.
|
PEGI | Hot Stocks09:06 EDT Pattern Energy provides operations update in light of recent weather events - Pattern Energy Group provided an update on its operations in light of the weather events in Puerto Rico and Texas. Most importantly, all team members and their families remained safe throughout the events and no injuries were reported. Highlights include: All Pattern Energy personnel are safe and no injuries were reported. No material damage has been found as a result of hurricanes Harvey, Irma or Maria. The operations team has been able to respond effectively to events and are working with the Puerto Rico Electric Power Authority to support its efforts to restore power locally. Pattern Energy is reaffirming its target 2017 cash available for distribution. Pattern Energy expects production below its long-term average in the third quarter of 2017 due to weather conditions.
|
ESV ATW | Hot Stocks09:05 EDT Egan-Jones recommends Ensco investors vote for Atwood Oceanics acquisition - Ensco (ESV) announced that independent proxy advisory firm Egan-Jones Rating Company has joined Glass Lewis in recommending that Ensco shareholders vote "FOR" the pending all-stock acquisition of Atwood Oceanics (ATW) at the company's upcoming general meeting of shareholders on 5 October 2017. The Egan-Jones recommendation affirms the strategic and financial rationale of the transaction and clear long-term value creation opportunity for Ensco shareholders. In making its recommendation, Egan-Jones noted that it views the proposed transaction "to be a desirable approach in maximizing shareholder value. After careful consideration, we believe that approval of the merger is in the best interests of the company and its shareholders and its advantages and opportunities outweigh the risks associated to the transaction." Ensco's Board of Directors unanimously recommends that Ensco shareholders vote "FOR" the proposal to combine with Atwood in an all-stock transaction at the upcoming general meeting of shareholders, which is necessary to complete the acquisition.
|
PVH | Hot Stocks09:02 EDT Marchon Eyewear, Calvin Klein renew eyewear licensing agreement - Marchon Eyewear and Calvin Klein, the wholly owned subsidiary of PVH Corp., announced the long-term, multi-year renewal of their global eyewear licensing agreement. This agreement is for the exclusive design, development, production and distribution of Calvin Klein's ophthalmic and sunglass collections, under the CALVIN KLEIN 205W39NYC, CALVIN KLEIN, and Calvin Klein Jeans brands. This renewal marks the 25 year milestone since Marchon and Calvin Klein first engaged as licensing partners in 1992.
|
HMTV | Hot Stocks08:59 EDT Hemisphere Media withdraws FY adjusted EBITDA guidance due to Hurricane Maria - Hemisphere Media Group provided the following statement regarding the impact of Hurricane Maria on its business: "As a result of the extraordinary scope and power of Hurricane Maria, there has been disruption to our business in Puerto Rico. While there was limited damage to our studios and offices, one of our three transmission towers was significantly damaged. The other two towers incurred only minimal damage. We are working to assess the full extent of the damage to the towers, as well as establishing a timeline for the necessary repairs. Presently, we have an interim solution through which we have been transmitting WAPA's signal, while we evaluate alternate transmission solutions. We believe we will be able to identify one or more acceptable solutions. Beyond physical damage, the extraordinary situation in Puerto Rico will adversely affect WAPA's business in the coming months. Resulting disruption from the storm, coupled with the uncertainty regarding timing for recovery of power and possible declines in television households, will have an adverse effect on revenue for several months. It is too soon to determine the timing for the recovery of business in Puerto Rico, which will largely depend on restoration of power to the island and the pace and progress of the rebuilding and recovery efforts. During the recovery period, we will be carefully managing our expenses to mitigate the impact of revenue losses, to the extent possible. We are confident that the federal government will provide substantial financial and logistical support, which, together with the resolve of Puerto Ricans, will result in a strong recovery. Although we are still estimating the impact of the property damage, we do expect insurance will cover most of the replacement costs, subject to deductibles and other costs. We also anticipate that a portion of the adverse impact to the operations of our business will be mitigated through business interruption insurance, although it will likely not offset the full extent of the revenue loss. There can be no assurances of the timing and amount of proceeds we may recover under our insurance policies. In the meantime, in order to continue to serve Puerto Ricans necessary and vital news and information, our studios and production facilities have been operating continuously via backup generators throughout and following the storm. Presently, WAPA is producing in-studio and on-location coverage of the aftermath of the hurricane to those on the island who are able to receive our signal. Additionally, all of our news coverage is being simulcast on WAPA America, providing Puerto Ricans and other interested viewers living in the U.S. with the only continuous coverage of this crisis. Many of our U.S. pay television distribution partners have temporarily made our WAPA America signal available to all of their subscribers, reflecting the importance of our network, and substantially expanding WAPA America's reach and coverage. As a result of Hurricane Maria and the associated uncertainty around the timing of the recovery in Puerto Rico, we are withdrawing our previously-provided full year 2017 Adjusted EBITDA guidance."
|
HON | Hot Stocks08:53 EDT Honeywell to raise dividend 12%, effective in Q4 - Honeywell announced that its Board of Directors has approved a 12% increase in the company's regular annual cash dividend from $2.66 to $2.98 per common share. The increase will be effective starting with the fourth quarter dividend of 74.5c per common share, which was declared earlier, and is payable on December 8, out of surplus to shareowners of record at the close of business on November 17.
|
GLW | Hot Stocks08:50 EDT Corning, Youngy Group for joint venture - Corning announced a joint venture agreement with Youngy Investment Holding Group to focus on glass laminates for interior architecture applications. Corning will supply glass laminate technologies and Corning Willow Glass to the joint venture. The joint venture will manufacture the panels, which will be used in residential and commercial applications, in Wuhu, China.
|
RDUS | Hot Stocks08:48 EDT Radius Health initiates Phase 1 clinical trial of RAD140 - Radius Health announced that the first patient has been enrolled in the company's Phase 1 study of RAD140, a nonsteroidal selective androgen receptor modulator, or SARM, undergoing clinical evaluation for the treatment of hormone receptor positive breast cancer. The clinical trial is designed to evaluate the safety and maximum tolerated dose of RAD140 in approximately 40 patients.
|
BDRBF | Hot Stocks08:35 EDT Bombardier signs Q400 turboprop order with SpiceJet for up to 50 planes - Bombardier announced that it has concluded a firm purchase agreement with SpiceJet of Gurgaon, India for up to 50 Q400 turboprop airliners, making it the largest single order ever for the Q400 turboprop aircraft program and bringing total Q400 firm orders to over 600 Q400 aircraft. Upon delivery, the airline will become the first in the world to operate a 90-seat turboprop, pending certification by regulatory authorities. The purchase agreement includes 25 Q400 turboprops and purchase rights on an additional 25 aircraft. Based on list prices, the order is valued at up to $1.7B.
|
GFF | Hot Stocks08:35 EDT Griffon expects Tuscan Path acquisition to add $20M in annualized revenue - Griffon Corporation announced that its subsidiary, The Ames Companies, completed the acquisition of Tuscan Landscape Group, an Australian provider of pots, planters, pavers, decorative stone, and garden decor products. The acquisition will broaden AMES' global outdoor living and lawn and garden business, and will strengthen AMES' industry leading position in Australia. The acquisition was completed under the terms of the previously announced purchase agreement entered into on August 25. The purchase price for Tuscan Path was approximately $18M. The acquisition is expected to contribute approximately $20M in annualized revenue and be immediately accretive to Griffon's earnings in its first full year of operations.
|
JEC NTOIY | Hot Stocks08:32 EDT Jacobs Engineering sells interest in Neste Jacobs Oy - Jacobs Engineering Group (JEC) announced that Jacobs has sold its 40% interest in Neste Jacobs Oy to the Neste Corporation (NTOIY). The purchase price has not been disclosed. After this transaction, Neste holds all shares in Neste Jacobs Oy. The sale of Jacobs' interest in Neste Jacobs Oy aligns with the company's strategy outlined last year to grow profitably by executing a balance of organic growth, acquisitions and active portfolio management that positions Jacobs in the most attractive end markets and geographies.
|
ECOM | Hot Stocks08:31 EDT ChannelAdvisor expands with planned Denver office - ChannelAdvisor announced it will expand its footprint with plans for a new office in Denver, Colorado. The Denver office will support additional members of the company's sales organization, an expansion designed to enable growth.
|
ECL | Hot Stocks08:31 EDT Ecolab to acquire Georgia-Pacific's paper chemicals business - Ecolab has signed an agreement to acquire the paper chemicals business from Georgia-Pacific. This business supplies differentiated products and applications that provide strength, softness and durability to paper. These products and applications will enhance Ecolab's position in the growing Tissue and Towel, as well as the Packaging and Board segments of the paper industry. The business had 2016 revenues of approximately $43M. The transaction is expected to be completed before the end of the year subject to customary closing conditions. Terms of the transaction were not disclosed. The acquisition will expand the paper industry offerings of Ecolab's Paper business, which provides innovative chemistries and solutions, to help producers improve their efficiency, water and energy savings, product quality, and profitability.
|
EHIC VLKAY | Hot Stocks08:22 EDT eHi Car Services partners with Volkswagen Group China - Volkswagen Group China (VLKAY) and eHi Car Services (EHIC) have signed a Memorandum of Understanding to jointly explore luxury mobility-on-demand services in China. Both parties will leverage innovative technologies, rapidly developing mobile Internet and car connectivity to provide luxury mobile services to Chinese consumers. Entirely new on-demand services will satisfy diverse needs, and make luxury mobility more comfortable and more convenient. To address the huge market potential, a strategic partnership will be formed which combines the strengths of Volkswagen and eHi's mobility services leadership in China, where it operates about 60,000 vehicles from more than 4,000 directly managed service locations in more than 250 cities.
|
TEX | Hot Stocks08:14 EDT Marcato boosts Terex stake to 6.2% from 5.2% - Marcato Capital Management disclosed an increased stake of 6.2% in Terex, representing over 5.5M shares. The activist fund disclosed a 5.2% stake on February 3.
|
BIOL | Hot Stocks08:12 EDT BIOLASE announces plans for rights offering to stockholders - BIOLASE announced that it has filed a Registration Statement on Form S-1 with the SEC for a rights offering to existing holders of its common stock. If the rights offering is successful, the company expects to receive gross proceeds of approximately $8M to $12M before expenses. Certain affiliates of Larry Feinberg and certain affiliates of Jack Schuler have each agreed with the company to exercise their respective basic subscription rights and any available over-subscription privilege pursuant to the rights offering in an amount not less than $3M and $3M respectively. The rights offering will be made through the company's distribution to its existing stockholders of non-transferable subscription rights to purchase their pro rata portion of newly issued shares of the Company's common stock. The subscription price has not yet been determined. The record date for the distribution of the rights and the dates for both the subscription period and the expiration of the rights offering will be included in the final prospectus.
|
ZLAB | Hot Stocks08:09 EDT Zai Lab reports dosing of first patient in Phase 3 registration trial of ZL-2306 - Zai Lab announced that it has dosed the first patient in a Phase 3 registration trial to evaluate the safety and efficacy of ZL-2306 for the maintenance treatment of patients with recurrent epithelial ovarian, fallopian tube and primary peritoneal cancer who are in a complete or partial response to platinum-based chemotherapy.
|
SUNW | Hot Stocks08:07 EDT Sunworks awarded 8.5 MW solar power project - Sunworks announced it has been awarded a new 8.5 megawatt solar power project in partnership with ForeFront Power, a leading solar power developer that assists private and public sector agencies by delivering the most impactful, behind-the-meter, virtual and wholesale renewable energy solutions. The new project directly supports an initiative from the end-customer to reduce costs and meet recent renewable energy goals. Sunworks will design, engineer, procure and install a combination of parking canopy and ground mount solar solutions at multiple locations. The projects are expected to result in reduced energy costs while establishing a definitive, long term pricing structure for the customer.
|
GWPH ZGNX | Hot Stocks08:05 EDT GW Pharmaceuticals slides after Zogenix Dravet data called 'best case' - Shares of GW Pharmaceuticals (GWPH) are sliding after Zogenix (ZGNX) reported that its first Phase 3 trial for its investigational drug, ZX008, met its primary objective of demonstrating that ZX008 is superior to placebo as adjunctive therapy in the treatment of Dravet syndrome. Leerink analyst Paul Matteis said the top-line results for the ZX008 study in Dravet Syndrome reported by Zogenix look like a "best case scenario" for the company, noting that the trial not only hit its endpoint but the magnitude of clinical benefit was better than expected. GW Pharmaceuticals is studying its own Epidiolex drug in children with Dravet syndrome. GW Pharma shares are down $15.27, or 13.6%, to $97.00 in pre-market trading.
|
CBRL | Hot Stocks08:04 EDT Cracker Barrel announces new $25M share repurchase authorization - The Board authorized new share repurchases for up to $25M of the company's outstanding common stock. The share repurchase authorization is effective immediately and replaces the prior authorization.
|
SVA | Hot Stocks08:03 EDT Sinobioway Consortium provides udpate on acquiring Sinovac Biotech - Sinobioway Consortium has provided an update on its offer to acquire Sinovac Biotech. The Sinobioway Consortium has sent all the new documents required by the Special Committee in September 1st, though still no official response has been heard from the Special Committee or the Board of Sinovac so far, including the new offer up to $8 per share submitted months ago. To better accomplish the partitioning during this process, Sinobioway Consortium revised the fund arrangement to make sure their proposed transaction will be 100% funded by immediately available offshore US dollars which are not subject to any relevant governmental approval or foreign exchange supervision. The Sinobioway Consortium is led by Dr. Pan, the Chairman of Shandong Sinobioway Biomedicine, and also the Co-founder of Sinovac and its principal operation subsidiary, Sinovac Beijing. As the Chairman of Sinovac Beijing, Dr. Pan owns veto power on matters such as expansion or amendment of creation of a mortgage or pledge upon the company's assets, a change in the organizational form of the company, and even the designation or removal of the general manager. Moreover, the Consortium is also comprised of several reputable enterprises and private equity funds with offshore cash-rich funds, like CICC Qianhai Development Fund Management Co., Ltd., which currently manages several funds whose total value amounts to 1.7B CNY, and GoldStone Investment Co., Ltd., the wholly owned subsidiary of CITIC Securities Co., Ltd., which is the largest listed security company in China. Therefore, concerns on the transaction equity to acquire Sinovac should be unnecessary. On August 31st, Shandong Sinobioway Biomedicine has announced its semiannual financial report, which revealed that the revenue and net profit of Sinovac Beijing, the principal operation subsidiary of Sinovac, was 474.56M CNY and 234.41M CNY from January to June of 2017, respectively. Sinovac has realized its rapid growth of both revenue and net profit. From the initial offer of $7 per share to the recent $8, Sinobioway Consortium has always bid higher than Yin's Consortium, and no matter what the cost will be, Sinobioway is capable of completing the Sinovac buyout and will never take giving up as its option.
|
MS | Hot Stocks08:02 EDT Morgan Stanley to acquire Mesa West Capital - Morgan Stanley Investment Management and Mesa West Capital announced they have entered into an agreement whereby MSIM will acquire Mesa West. With over $5B in gross assets under management, Mesa West will add a premiere commercial real estate credit platform to MSIM's existing investment strategies and product offerings across real assets and private credit. Mesa West will retain its brand and operate as a separate business unit within MSIM's Real Assets group, which currently manages $47B of client assets and is overseen by John Klopp, global head of real assets. The company's headquarters will remain in Los Angeles, and Mesa West senior management, led by co-founders Jeff Friedman and Mark Zytko, will continue to manage the company on a day-to-day basis. The transaction is subject to customary closing conditions, including obtaining applicable regulatory approvals and requisite investor consents, and is expected to close in Q4.
|
SYRS | Hot Stocks08:02 EDT Syros to present biomarker data from ongoing Phase 2 SY-1425 trial at ESH - Syros Pharmaceuticals said it will present biomarker data from its ongoing Phase 2 clinical trial of SY-1425, an oral first-in-class selective retinoic acid receptor alpha agonist, in genomically defined subsets of patients with acute myeloid leukemia and myelodysplastic syndrome at the European School of Haematology's 4th International Conference on Acute Myeloid Leukemia "Molecular and Translational": Advances in Biology and Treatment taking place October 5-7 in Estoril, Portugal. The presentation will describe Syros' proprietary RARA and IRF8 biomarkers, including their prevalence in AML and MDS patients screened for enrollment in the Phase 2 clinical trial to date. The presentation will also include data correlating biomarker status with myeloid differentiation in cells taken from patients upon screening for the trial and then treated ex vivo with SY-1425.
|
AMAG | Hot Stocks08:01 EDT Amag Pharmaceuticals appoints Tracy Palmer Berns as Chief Compliance Officer - AMAG Pharmaceuticals announced the appointment of Tracy Palmer Berns as Chief Compliance Officer effective immediately. She will report to Joseph Vittiglio, general counsel and senior vice president of legal affairs and quality. In her role at AMAG, Berns will be responsible for the company's compliance program and therapeutic-product legal team and provide legal advice on regulatory, development, pharmacovigilance and quality matters. Additionally, she will further strengthen the organization's culture to continue to prioritize ethics and compliance.
|
ZGNX | Hot Stocks07:42 EDT Zogenix share price triples after Dravet syndrome trial meets endpoint - In pre-market trading, Zogenix shares are up $26.18, or 203%, to $39.05 after the company reported that its first Phase 3 trial for its investigational drug, ZX008, met its primary objective of demonstrating that ZX008 is superior to placebo as adjunctive therapy in the treatment of Dravet syndrome. Zogenix closed yesterday at $12.88.
|
ZGNX | Hot Stocks07:36 EDT Zogenix trading resumes
|
TGTX | Hot Stocks07:35 EDT TG Therapeutics says TGR-1202 selected for grant from NMSS - TG Therapeutics announced that it has entered into a Sponsored Research Agreement with the National Multiple Sclerosis Society through Fast Forward, its not for profit subsidiary. Under the agreement, Fast Forward will provide funding to TG Therapeutics to further the preclinical development of TGR-1202, the company's novel PI3K-delta inhibitor, as a potential oral treatment option for progressive forms of Multiple Sclerosis. TGR-1202 was selected by Fast Forward through a competitive selection process based on its potential in the treatment of PMS. Dr. Lawrence Steinman, MD, of Stanford University will lead the research team on this effort.
|
BA | Hot Stocks07:33 EDT Boeing announces five-year service agreement with Azores Airlines - Boeing, through its subsidiary Jeppesen, announced a five-year service agreement with Azores Airlines, a part of SATA, to provide digital flight operations solutions so the airline can begin to eliminate paper-based materials to increase operational efficiency and reduce costs. Specifically, Jeppesen will provide the carrier initially with both digital and paper charting materials and FliteDeck Pro electronic flight bag services on iPad, which will reduce preparation time and allow pilots to quickly access needed information on a screen top. Azores Airlines will also implement Jeppesen's JetPlan and Skybook services.
|
NNVC | Hot Stocks07:32 EDT NanoViricides says has sufficient cash to advance into clinical trials - The company said, "We do not anticipate any major capital costs going forward in the near future. Based on the current rate of expenditures (excluding capital costs), we believe that we have sufficient funds in hand to last more than one year. In addition, in order to conserve cash expenditures, we also pay compensation in stock and stock instruments to various parties. Thus, the Company has ended the year on a strong financial footing. We project, based on various estimates that we have obtained, that our current available financing is sufficient for accomplishing the goal of filing at least one IND or equivalent regulatory application for at least one of our drug candidates. We believe that we will need to raise additional financing for conducting the clinical trials to get our first drug licensed by the US FDA or another regulatory authority so that we can enter commercial revenue-producing stage of our business plan. We believe that clinical trials for our lead candidate (shingles treatment) would be relatively less expensive being a topical treatment, as opposed to our injectable drugs in development."
|
MRK | Hot Stocks07:09 EDT Merck to present new, updated clinical data on Keytruda at WCLC - Merck announced that new and updated data investigating KEYTRUDA, the company's anti-PD-1 therapy, across multiple lung malignancies, including non-small cell lung cancer, will be presented at the 18th World Conference on Lung Cancer hosted by the International Association for the Study of Lung Cancer in Yokohama, Japan, Oct. 15-18. Results from studies in first-line NSCLC - updated overall survival findings from the phase 3 KEYNOTE-024 trial evaluating KEYTRUDA as a monotherapy, and an encore of additional five months of follow-up from the randomized G cohort of the phase 2 KEYNOTE-021 trial evaluating KEYTRUDA in combination with pemetrexed/carboplatin - will be presented. Additional data in novel combinations and real-world evidence will also be shared. Merck has an extensive research program in NSCLC and is currently advancing multiple registration-enabling studies with KEYTRUDA as monotherapy and in combination with other treatments.
|
VKTX | Hot Stocks07:07 EDT Viking Therapeutics enters $16.25M stock purchase agreement with Lincoln Park - Viking Therapeutics announced it has entered into a $15M common stock purchase agreement with Lincoln Park Capital Fund. In addition and under a separate purchase agreement, LPC has agreed to purchase $1.25M of Viking's registered common stock at $1.78 per share, which represents a 14% premium to the closing market price of the stock on September 27. Under the common stock purchase agreement, Viking will have the right and sole discretion to sell to LPC up to $15M in shares of common stock over a 30-month period contingent and commencing upon the effectiveness of the resale registration statement discussed below and satisfaction of other conditions contained in the agreement. Proceeds from the sales will be used for general corporate purposes, including advancing the company's drug development pipeline.
|
AVXS | Hot Stocks07:07 EDT AveXis plans to initiate pivotal trial of AVXS-101 - AveXis announced the FDA has notified the company that based on review of data submitted, including the potency assay, it may initiate its planned pivotal trial of AVXS-101 for patients with spinal muscular atrophy, or SMA, Type 1 using the intravenous formulation produced by the company's Good Manufacturing Practice commercial manufacturing process. The company plans to initiate this trial immediately.
|
ZGNX | Hot Stocks07:06 EDT Zogenix says ZX008 Phase 3 trial met primary endpoint - Zogenix reported positive top-line results from its first Phase 3 trial for its investigational drug, ZX008, for the treatment of Dravet syndrome. The trial met its primary objective of demonstrating that ZX008, at a dose of 0.8 mg/kg/day, is superior to placebo as adjunctive therapy in the treatment of Dravet syndrome in children and young adults based on change in the frequency of convulsive seizures between the 6-week baseline observation period and the 14-week treatment period. ZX008 0.8 mg/kg/day also demonstrated statistically significant improvements versus placebo in all key secondary measures, including the proportion of patients with clinically meaningful reductions in seizure frequency and longest seizure-free interval. The same analyses comparing a 0.2 mg/kg/day ZX008 dose versus placebo also demonstrated statistically significant improvement compared with placebo. The primary efficacy measure was a comparison of the change in mean monthly convulsive seizure frequency between ZX008 0.8 mg/kg/day and placebo during the 14-week treatment period compared with the 6-week baseline observation period. Patients taking ZX008 0.8 mg/kg/day achieved a 63.9% reduction in mean monthly convulsive seizures compared to placebo. The median percent reduction in monthly convulsive seizure frequency was 72.4% among ZX008 0.8 mg/kg/day patients compared to 17.4% in placebo patients.
|
RBA | Hot Stocks07:05 EDT Ritchie Bros. sells over $52M of equipment, trucks in Fort Worth, TX - Ritchie Bros. held a two-day auction at its site in Fort Worth, TX this week, selling 3,800+ equipment items and trucks for over $52M.
|
KTWO | Hot Stocks07:04 EDT K2M Group receives FDA clearance for YUKON OCT Spinal System - K2M Group announced that it has received 510(k) clearance from the FDA for its YUKON OCT Spinal System. YUKON OCT offers surgeons an advanced system aimed at facilitating fusion with posterior fixation in the occipito-cervico-thoracic regions of the spine with the goal of helping to achieve three-dimensional spinal balance.
|
DB... | Hot Stocks07:03 EDT Fitch downgrades Deutsche Bank rating to 'BBB+,' upgrades UBS to 'A+' - Fitch Ratings last night announced it concluded its periodic review of the Global Trading and Universal Banks, which comprises 12 large and globally active banks. Fitch has affirmed the issuer ratings of 10 of the 12 GTUB parent entities. Fitch upgraded UBS Group's (UBS) Long-Term Issuer Default Rating, or IDR, to 'A+' from 'A' to reflect its view that the group has improved its business by reducing tail risk, which should allow it to generate sound and less volatile earnings. Fitch downgraded Deutsche Bank's (DB) Long-Term IDR to 'BBB+' because it sees continued pressure on earnings, combined with a prolonged execution of its strategy. Following the review, the GTUB parent entities' Long-Term IDRs range from 'BBB+' for Deutsche Bank to 'AA-' for HSBC (HSBC), with one GTUB parent, Credit Suisse (CS), rated 'A-', BNP Paribas (BNPQY), JPMorgan Chase (JPM) and UBS rated 'A+' and the others - Bank of America (BAC), Barclays (BCS), Citigroup (C), Goldman Sachs (GS), Morgan Stanley (MS) and Societe Generale (SCGLY) - rated 'A'. All parent entities have Stable Outlooks.
|
VRX CG | Hot Stocks07:03 EDT Valeant completes sale of iNova Pharmaceuticals to Carlyle Group, Pacific Equity - Valeant (VRX) announced that it has completed the sale of the iNova Pharmaceuticals business to a company jointly owned by funds advised and managed by Pacific Equity Partners and The Carlyle Group (CG) for $930M in cash. Valeant will use net proceeds of approximately $920M from the sale to repay term loan debt under its Senior Credit Facility. Additionally, the company is utilizing cash from operations to repay $100M of amounts outstanding under its revolving credit facility. Following the closure of the sale of the Obagi Medical Products business, which remains on track to close in 2017, Valeant expects it will exceed its August 2016 commitment to pay down $5B in debt from divestiture proceeds and free cash flow before February 2018. The company estimates that the expected revenue and Adjusted EBITDA from the iNova business in the fourth quarter of 2017 would have been approximately $65M and $35M, respectively.
|
SPPI | Hot Stocks07:02 EDT Spectrum sees $90.2M in proceeds from at-the-market facility - Spectrum Pharmaceuticals announced that between August 11 and September 29, it issued an aggregate of approximately 9.3M shares of its common stock under its previously announced "at-the-market" offering program, resulting in aggregate net proceeds to the company of approximately $90.2M. The company expects to use the proceeds from this financing to continue to develop its pipeline and to provide additional flexibility to its capital structure.
|
VVV | Hot Stocks07:01 EDT Valvoline board unanimously picks Stephen Kirk as new chairman
|
VVV ASH | Hot Stocks07:01 EDT Valvoline says William Wulfsohn to step down as chairman, retire from board - Valvoline (VVV) announced that William A. Wulfsohn, who served as Valvoline's founding chairman during its initial year as a public company, will step aside from his position as chairman of the board as of September 30, the company's fiscal year end. Wulfsohn has also stated he will not stand for re-election at the company's 2018 annual shareholder meeting. Wulfsohn is chairman and CEO of Ashland Global Holdings (ASH), Valvoline's former parent company. Wulfsohn joined Valvoline's board last year to guide Valvoline through its separation from Ashland and first year as a publicly traded company. Wulfsohn's announcement that he will step aside as chairman and later retire from his board position at Valvoline comes one year following Valvoline's initial public offering in September 2016. The board has unanimously named Stephen F. Kirk to replace Wulfsohn as board chairman. Kirk has served as an independent director on Valvoline's board and is the chair of Valvoline's compensation committee.
|
MRK | Hot Stocks06:56 EDT Merck discontinues MK-3682B, MK-3682C development programs - Merck announced its strategic decision to discontinue the development of the investigational combination regimens MK-3682B and MK-3682C for the treatment of chronic hepatitis C virus infection. This decision was made based on a review of available Phase 2 efficacy data and in consideration of the evolving marketplace and the growing number of treatment options available for patients with chronic HCV infection, including ZEPATIER.
|
ZGNX | Hot Stocks06:55 EDT Zogenix trading halted, news pending
|
FENG | Hot Stocks06:34 EDT Phoenix New Media announces short-term extension of license agreement - Phoenix New Media announced that it has reached an agreement with its parent company, Phoenix Satellite Television Holdings, to extend the expiration date of the existing trademark license agreement between certain consolidated affiliated entities of the company and a subsidiary of Phoenix TV from October 8, 2017 to December 8, 2017. Pursuant to the Existing Agreement, Phoenix TV has been licensing its trademarks to the company for use in its businesses. The company and Phoenix TV are working on a new agreement to amend and replace the Existing Agreement and provide the terms of their future trademark licenses. Considering the various internal procedures and compliance requirements to be satisfied before the New Agreement can be finalized and become effective, both the company and Phoenix TV agreed to extend the Existing Agreement's expiration date to December 8, 2017 or when the parties conclude the New Agreement.
|
CG | Hot Stocks06:15 EDT Carlyle Group to sell Klenk Holz AG to Binderholz - The Carlyle Group and Binderholz GmbH announced that they have signed a definitive agreement under which Carlyle will sell Klenk Holz AG, a German manufacturer of wood products, to Binderholz GmbH, based in Fugen, Austria. The transaction is expected to close by the end of the year. Further details of the transaction were not disclosed.
|
NWS NWSA | Hot Stocks06:13 EDT Wall Street Journal to stop publishing Europe, Asia print editions - The Wall Street Journal will stop publishing the European and Asian print editions of the newspaper over the next week, as the company shifts its focus to digital amid an increasingly challenged print advertising market. The final print edition in Europe will be this Friday, with Asia's print publication ceasing after next Friday, company officials confirmed. The reduction of the paper's print presence comes amid a broad reorganization of the Journal's editorial structure to transform the newspaper into a mobile-first news operation. The Journal, a unit of News Corp , launched an initiative called WSJ2020 in October 2016 to revamp operations as the news industry undergoes a shift toward digital and mobile. Reference Link
|
VLKAY | Hot Stocks06:07 EDT Volkswagen increases provision for recall actions in North America - The Volkswagen Group said that in the third quarter negative special items of ca. EUR2.25B are expected to burden the Operating Result. The reason is an increase in provisions relating to the buyback/retrofit program for 2,0l TDI vehicles, which is part of the settlements in North America that is proving to be far more technically complex and time consuming. The complete Interim Report of the Volkswagen Group for the period January-September 2017 will be published on October 27th.
|
TSM | Hot Stocks05:51 EDT TSMC to build 3nm fab in Tainan Science Park - TSMC announced that, following careful evaluation, the company's planned advanced 3nm fab will be located in the Tainan Science Park to fully leverage the company's existing cluster advantage and the benefit of a comprehensive supply chain. TSMC recognizes and is grateful for the government's clear commitments to resolve any issues, including land, water, electricity and environmental protection.
|
LN | Hot Stocks05:43 EDT LINE Corp. establishes new subsidiary by company split - LINE Corporation announced that the company has decided at the board meeting to establish a new subsidiary, Next Library, by a simplified incorporation-type company split to succeed the company's businesses relating to the NAVER Matome related business. Since this is a simplified incorporation-type company split solely involving the company, certain information is omitted from this announcement. The LINE Group operates a user participation-type search service within Japan called NAVER Matome, which allows general users to create webpages by compiling images, links, and videos on a specific topic. To accelerate the decision-making process and execution thereof for the Business, the company has decided to convert the Business into a wholly owned subsidiary by means of a company split. Through these means, the company aims to improve the corporate value of the entire LINE Group by promoting greater mobility for the Business and expanding beyond the NAVER Matome service to branch out into various other user-participation services.
|
CYOU | Hot Stocks05:39 EDT Changyou.com appoints Yaobin Wang as CFO - Changyou.com announced the appointment of Yaobin Wang as its CFO. Wang brings with him extensive experience in financial management, having held many senior management positions previously in a number of internet companies where he oversaw finance, legal and M&A functions.
|
BBRY | Hot Stocks05:35 EDT BlackBerry enters partnership with Tokyo Electron Device - BlackBerry and Tokyo Electron Device, or TED, announced they have signed a new sales and distribution agreement, which will provide device manufacturers in Japan with access to BlackBerry's QNX Software Development Platform 7.0 - the most advanced and secure embedded platform on the market.
|
ALR | Hot Stocks05:34 EDT Alere announces agreement in principle to settle with DOJ - Alere announced that it has reached an agreement in principle to settle with the U.S. Department of Justice to resolve various potential civil claims, including claims under the False Claims Act, relating to Alere Triage cardiac and Toxicology products sold between January 2006 and March 31, 2012. The settlement relates to matters arising out of the previously disclosed 2012 FDA inspection of Alere San Diego and the Office of Inspector General subpoena. Alere issued the following statement: "We have cooperated with the DOJ investigation, and we are pleased to reach this agreement in principle that would fully resolve this matter with DOJ. If the ongoing discussions with the DOJ are successfully concluded, we believe the total combined payment to the Department of Justice and the participating states will be within the $35M loss contingency reserve previously taken by the company."
|
ALR | Hot Stocks05:33 EDT Alere announces agreement in principle to settle with DOJ - Alere announced that it has reached an agreement in principle to settle with the U.S. Department of Justice to resolve various potential civil claims, including claims under the False Claims Act, relating to Alere Triage(R) cardiac and Toxicology products sold between January 2006 and March 31, 2012. The settlement relates to matters arising out of the previously disclosed 2012 FDA inspection of Alere San Diego and the Office of Inspector General subpoena. Alere issued the following statement: "We have cooperated with the DOJ investigation, and we are pleased to reach this agreement in principle that would fully resolve this matter with DOJ. If the ongoing discussions with the DOJ are successfully concluded, we believe the total combined payment to the Department of Justice and the participating states will be within the $35 million loss contingency reserve previously taken by the company."
|
SJW | Hot Stocks05:30 EDT SJW Group CEO W. Richard Roth to retire Nov. 5, Eric Thornburg to succeed - SJW Group announced that W. Richard Roth will retire as president and CEO of SJW Group on November 5. The board has appointed Eric Thornburg as the new president and CEO and a member of the board beginning November 6. Roth will serve as Chief Executive Emeritus until December 31, to ensure a seamless transition and will remain the chairman of the board until the next annual meeting of stockholders. The company anticipates appointing Thornburg as chairman of the board following such meeting. Thornburg has served for the last 10 years as the president and CEO of Connecticut Water Service.
|